Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Radium-223 in Prostate Cancer Patients With Painful Bone Metastases
NCT00459654Phase 2Completed
- Sponsor
- Bayer
- Start
- Feb 2004
- Primary completion
- May 2006
- Modality
- Radiopharmaceutical
- Countries
- 2
01
Overview
A Phase 2 trial of radium-223 dichloride in prostate cancer (PCa), sponsored by Bayer. Started Feb 2004; status: completed.
02
Drugs
radium-223 dichloride
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00459654.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00459654.